(Reuters) - Rare disease drugmaker Shire Pharmaceuticals Plc is preparing to announce its roughly $32.5 billion acquisition of U.S. peer Baxalta International Inc as early as Monday, according to people familiar with the matter.
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire